Drugs

SFDA Guidance for Drafting Risk Management Plans of COVID-19 Vaccines

2021-09-05
SFDA Guidance for Drafting Risk Management Plans of COVID-19 Vaccines
Guide
Has the page content helped you?

SFDA Guidance for Periodic Safety Update Reports of COVID-19 Vaccines

2021-09-05
SFDA Guidance for Periodic Safety Update Reports of COVID-19 Vaccines
Guide
Has the page content helped you?

Conditions and requirements for obtaining permits for drugs , pharmaceuticals , and cosmetics products for individuals for personal use

2025-10-27
Conditions and requirements for obtaining permits for drugs , pharmaceuticals , and cosmetics products for individuals for personal use
Requirement
Has the page content helped you?

Clinical Considerations for Vaccines

2021-08-15
Clinical Considerations for Vaccines
Guide
Has the page content helped you?

GCC VNeeS Validation Criteria

2021-07-11
GCC VNeeS Validation Criteria
Has the page content helped you?

Saudi Code of Conduct for Promotional Practices of Pharmaceutical and Herbal Product in the Kingdom of Saudi Arabia

2024-02-04
Saudi Code of Conduct for Promotional Practices of Pharmaceutical and Herbal Product in the Kingdom of Saudi Arabia
Guide
Has the page content helped you?

Veterinary Products Law In Arab Gulf Cooperation Council Countries

2021-06-23
Veterinary Products Law In Arab Gulf Cooperation Council Countries
List
Has the page content helped you?

Code Procedures of Importing and Exporting

2021-05-09
Code Procedures of Importing and Exporting
Guide
Has the page content helped you?

Veterinary Incentive Project List

2021-06-10
Veterinary Incentive Project List
Has the page content helped you?

"SFDA" Withdraws and Suspends the Registration of (Omiz Plus 20mg, 40mg)

The Saudi Food & Drug Authority (SFDA) has announced the withdrawal and suspension of registration of Omiz Plus 40/1100mg Capsule with registration number (244-277-12), and Omiz Plus 20/1100 mg Capsule with registration number (245-277-12).

SFDA added that, the medicines produced by Tabuk Pharmaceuticals.  

  • To report sector-related issues

  • Call Centre 19999

Other Warnings

All Warnings
Subscribe to Drugs